Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: KBV Research | PRODUCT CODE: 1719577

Cover Image

PUBLISHER: KBV Research | PRODUCT CODE: 1719577

Europe Computational Pathology Market Size, Share & Trends Analysis Report By Component (Software and Services), By Application, By End-use, By Technology, By Country and Growth Forecast, 2025 - 2032

PUBLISHED:
PAGES: 149 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF (Single User License)
USD 1500
PDF (Multi User License)
USD 1800
PDF (Corporate User License)
USD 2520

Add to Cart

The Europe Computational Pathology Market would witness market growth of 7.7% CAGR during the forecast period (2025-2032).

The Germany market dominated the Europe Computational Pathology Market by Country in 2024, and would continue to be a dominant market till 2032; thereby, achieving a market value of $74.3 million by 2032. The UK market is exhibiting a CAGR of 6.7% during (2025 - 2032). Additionally, The France market would experience a CAGR of 8.4% during (2025 - 2032).

Traditional pathology involves examining physical tissue slides under a microscope, which is time-consuming and relies on the pathologist's subjective interpretation. These pathology employs AI and machine learning algorithms to analyze digital pathology images, identifying patterns and abnormalities in tissue samples that the human eye might miss.

The most prominent application of these pathology lies in the diagnosis and prognosis of cancer. Pathologists can use advanced image analysis tools to study digital slides of tissue biopsies, enabling early detection of cancerous cells, monitoring disease progression, and predicting treatment outcomes. Algorithms can assess features such as tumour size, shape, and texture, providing valuable insights into the malignancy of the tumour.

The market in the region is witnessing robust growth, driven by the increasing prevalence of chronic diseases, rising healthcare investments, and the region's strong focus on research and development (R&D). As countries strive to modernize healthcare delivery and improve diagnostic accuracy, computational pathology-which leverages AI and digital imaging for advanced disease diagnosis-is gaining traction across hospitals, research institutes, and diagnostic labs. Trends in Belgium, the broader European Union (EU), and the United Kingdom (UK) influence the market's upward trajectory. Belgium stands out as a European leader in research, with $1.64 billion (€1.5 billion) spent annually on R&D, representing 40% of all private investment in the country. This high level of investment creates a fertile ecosystem for developing and implementing cutting-edge healthcare technologies, including computational pathology. The strong collaboration between academia, industry, and healthcare providers in Belgium facilitates innovation in digital diagnostics. As R&D initiatives increasingly focus on personalized medicine and AI-powered diagnostics, computational pathology is expected to see growing adoption for both clinical and research applications. In conclusion, Belgium's R&D leadership, the EU's pressing health challenges, and the UK's growing healthcare investment are converging to drive the rapid adoption of these pathology technologies across Europe.

Based on Component, the market is segmented into Software and Services. Based on Application, the market is segmented into Disease Diagnosis, Drug Discovery & Development, and Academic Research. Based on End-use, the market is segmented into Hospitals and Diagnostic Labs, Biotechnology & Pharmaceutical Companies, Academic and Research Institutes, and Other End-use. Based on Technology, the market is segmented into Machine Learning (ML), (Deep Learning and Other Machine Learning (ML)), Computer Vision, Natural Language Processing (NLP) Models, and Other Technology. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.

List of Key Companies Profiled

  • Koninklijke Philips N.V.
  • F. Hoffmann-La Roche Ltd.
  • PathAI, Inc.
  • Hamamatsu Photonics K.K.
  • Olympus Corporation
  • Visiopharm A/S
  • Mikroscan Technologies, Inc.
  • MindPeak GmbH
  • Indica Labs, LLC
  • Nucleai, Inc. (Nucleai)

Europe Computational Pathology Market Report Segmentation

By Component

  • Software
  • Services

By Application

  • Disease Diagnosis
  • Drug Discovery & Development
  • Academic Research

By End-use

  • Hospitals and Diagnostic Labs
  • Biotechnology & Pharmaceutical Companies
  • Academic and Research Institutes
  • Other End-use

By Technology

  • Machine Learning (ML)
    • Deep Learning
    • Other Machine Learning (ML)
  • Computer Vision
  • Natural Language Processing (NLP) Models
  • Other Technology

By Country

  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe

Table of Contents

Chapter 1. Market Scope & Methodology

  • 1.1 Market Definition
  • 1.2 Objectives
  • 1.3 Market Scope
  • 1.4 Segmentation
    • 1.4.1 Europe Computational Pathology Market, by Component
    • 1.4.2 Europe Computational Pathology Market, by Application
    • 1.4.3 Europe Computational Pathology Market, by End-use
    • 1.4.4 Europe Computational Pathology Market, by Technology
    • 1.4.5 Europe Computational Pathology Market, by Country
  • 1.5 Methodology for the research

Chapter 2. Market at a Glance

  • 2.1 Key Highlights

Chapter 3. Market Overview

  • 3.1 Introduction
    • 3.1.1 Overview
      • 3.1.1.1 Market Composition and Scenario
  • 3.2 Key Factors Impacting the Market
    • 3.2.1 Market Drivers
    • 3.2.2 Market Restraints
    • 3.2.3 Market Opportunities
    • 3.2.4 Market Challenges

Chapter 4. Competition Analysis - Global

  • 4.1 KBV Cardinal Matrix
  • 4.2 Recent Industry Wide Strategic Developments
    • 4.2.1 Partnerships, Collaborations and Agreements
    • 4.2.2 Product Launches and Product Expansions
  • 4.3 Market Share Analysis, 2024
  • 4.4 Top Winning Strategies
    • 4.4.1 Key Leading Strategies: Percentage Distribution (2021-2025)
    • 4.4.2 Key Strategic Move: (Partnerships, Collaborations & Agreements : 2022, Mar - 2025, Feb) Leading Players
  • 4.5 Porter Five Forces Analysis

Chapter 5. Europe Computational Pathology Market by Component

  • 5.1 Europe Software Market by Country
  • 5.2 Europe Services Market by Country

Chapter 6. Europe Computational Pathology Market by Application

  • 6.1 Europe Disease Diagnosis Market by Country
  • 6.2 Europe Drug Discovery & Development Market by Country
  • 6.3 Europe Academic Research Market by Country

Chapter 7. Europe Computational Pathology Market by End-use

  • 7.1 Europe Hospitals and Diagnostic Labs Market by Country
  • 7.2 Europe Biotechnology & Pharmaceutical Companies Market by Country
  • 7.3 Europe Academic and Research Institutes Market by Country
  • 7.4 Europe Other End-use Market by Country

Chapter 8. Europe Computational Pathology Market by Technology

  • 8.1 Europe Machine Learning (ML) Market by Country
  • 8.2 Europe Computational Pathology Market by Machine Learning (ML) Type
    • 8.2.1 Europe Deep Learning Market by Country
    • 8.2.2 Europe Other Machine Learning (ML) Market by Country
  • 8.3 Europe Computer Vision Market by Country
  • 8.4 Europe Natural Language Processing (NLP) Models Market by Country
  • 8.5 Europe Other Technology Market by Country

Chapter 9. Europe Computational Pathology Market by Country

  • 9.1 Germany Computational Pathology Market
    • 9.1.1 Germany Computational Pathology Market by Component
    • 9.1.2 Germany Computational Pathology Market by Application
    • 9.1.3 Germany Computational Pathology Market by End-use
    • 9.1.4 Germany Computational Pathology Market by Technology
      • 9.1.4.1 Germany Computational Pathology Market by Machine Learning (ML) Type
  • 9.2 UK Computational Pathology Market
    • 9.2.1 UK Computational Pathology Market by Component
    • 9.2.2 UK Computational Pathology Market by Application
    • 9.2.3 UK Computational Pathology Market by End-use
    • 9.2.4 UK Computational Pathology Market by Technology
      • 9.2.4.1 UK Computational Pathology Market by Machine Learning (ML) Type
  • 9.3 France Computational Pathology Market
    • 9.3.1 France Computational Pathology Market by Component
    • 9.3.2 France Computational Pathology Market by Application
    • 9.3.3 France Computational Pathology Market by End-use
    • 9.3.4 France Computational Pathology Market by Technology
      • 9.3.4.1 France Computational Pathology Market by Machine Learning (ML) Type
  • 9.4 Russia Computational Pathology Market
    • 9.4.1 Russia Computational Pathology Market by Component
    • 9.4.2 Russia Computational Pathology Market by Application
    • 9.4.3 Russia Computational Pathology Market by End-use
    • 9.4.4 Russia Computational Pathology Market by Technology
      • 9.4.4.1 Russia Computational Pathology Market by Machine Learning (ML) Type
  • 9.5 Spain Computational Pathology Market
    • 9.5.1 Spain Computational Pathology Market by Component
    • 9.5.2 Spain Computational Pathology Market by Application
    • 9.5.3 Spain Computational Pathology Market by End-use
    • 9.5.4 Spain Computational Pathology Market by Technology
      • 9.5.4.1 Spain Computational Pathology Market by Machine Learning (ML) Type
  • 9.6 Italy Computational Pathology Market
    • 9.6.1 Italy Computational Pathology Market by Component
    • 9.6.2 Italy Computational Pathology Market by Application
    • 9.6.3 Italy Computational Pathology Market by End-use
    • 9.6.4 Italy Computational Pathology Market by Technology
      • 9.6.4.1 Italy Computational Pathology Market by Machine Learning (ML) Type
  • 9.7 Rest of Europe Computational Pathology Market
    • 9.7.1 Rest of Europe Computational Pathology Market by Component
    • 9.7.2 Rest of Europe Computational Pathology Market by Application
    • 9.7.3 Rest of Europe Computational Pathology Market by End-use
    • 9.7.4 Rest of Europe Computational Pathology Market by Technology
      • 9.7.4.1 Rest of Europe Computational Pathology Market by Machine Learning (ML) Type

Chapter 10. Company Profiles

  • 10.1 Koninklijke Philips N.V.
    • 10.1.1 Company Overview
    • 10.1.2 Financial Analysis
    • 10.1.3 Segmental and Regional Analysis
    • 10.1.4 Research & Development Expense
    • 10.1.5 Recent strategies and developments:
      • 10.1.5.1 Partnerships, Collaborations, and Agreements:
    • 10.1.6 SWOT Analysis
  • 10.2 F. Hoffmann-La Roche Ltd.
    • 10.2.1 Company Overview
    • 10.2.2 Financial Analysis
    • 10.2.3 Segmental and Regional Analysis
    • 10.2.4 Research & Development Expense
    • 10.2.5 Recent strategies and developments:
      • 10.2.5.1 Partnerships, Collaborations, and Agreements:
      • 10.2.5.2 Product Launches and Product Expansions:
    • 10.2.6 SWOT Analysis
  • 10.3 PathAI, Inc.
    • 10.3.1 Company Overview
    • 10.3.2 Recent strategies and developments:
      • 10.3.2.1 Partnerships, Collaborations, and Agreements:
      • 10.3.2.2 Product Launches and Product Expansions:
    • 10.3.3 SWOT Analysis
  • 10.4 Hamamatsu Photonics K.K.
    • 10.4.1 Company Overview
    • 10.4.2 Financial Analysis
    • 10.4.3 Segmental Analysis
    • 10.4.4 Research & Development Expense
    • 10.4.5 SWOT Analysis
  • 10.5 Olympus Corporation
    • 10.5.1 Company Overview
    • 10.5.2 Financial Analysis
    • 10.5.3 Segmental and Regional Analysis
    • 10.5.4 SWOT Analysis
  • 10.6 Visiopharm A/S
    • 10.6.1 Company Overview
    • 10.6.2 Recent strategies and developments:
      • 10.6.2.1 Partnerships, Collaborations, and Agreements:
      • 10.6.2.2 Product Launches and Product Expansions:
    • 10.6.3 SWOT Analysis
  • 10.7 Mikroscan Technologies, Inc.
    • 10.7.1 Company Overview
  • 10.8 MindPeak GmbH
    • 10.8.1 Company Overview
    • 10.8.2 Recent strategies and developments:
      • 10.8.2.1 Partnerships, Collaborations, and Agreements:
  • 10.9 Indica Labs, Inc.
    • 10.9.1 Company Overview
    • 10.9.2 Recent strategies and developments:
      • 10.9.2.1 Partnerships, Collaborations, and Agreements:
    • 10.9.3 SWOT Analysis
  • 10.10. Nucleai, Inc. (Nucleai)
    • 10.10.1 Company Overview
    • 10.10.2 Recent strategies and developments:
      • 10.10.2.1 Partnerships, Collaborations, and Agreements:

LIST OF TABLES

  • TABLE 1 Europe Computational Pathology Market, 2021 - 2024, USD Million
  • TABLE 2 Europe Computational Pathology Market, 2025 - 2032, USD Million
  • TABLE 3 Partnerships, Collaborations and Agreements- Computational Pathology Market
  • TABLE 4 Product Launches And Product Expansions- Computational Pathology Market
  • TABLE 5 Europe Computational Pathology Market by Component, 2021 - 2024, USD Million
  • TABLE 6 Europe Computational Pathology Market by Component, 2025 - 2032, USD Million
  • TABLE 7 Europe Software Market by Country, 2021 - 2024, USD Million
  • TABLE 8 Europe Software Market by Country, 2025 - 2032, USD Million
  • TABLE 9 Europe Services Market by Country, 2021 - 2024, USD Million
  • TABLE 10 Europe Services Market by Country, 2025 - 2032, USD Million
  • TABLE 11 Europe Computational Pathology Market by Application, 2021 - 2024, USD Million
  • TABLE 12 Europe Computational Pathology Market by Application, 2025 - 2032, USD Million
  • TABLE 13 Europe Disease Diagnosis Market by Country, 2021 - 2024, USD Million
  • TABLE 14 Europe Disease Diagnosis Market by Country, 2025 - 2032, USD Million
  • TABLE 15 Europe Drug Discovery & Development Market by Country, 2021 - 2024, USD Million
  • TABLE 16 Europe Drug Discovery & Development Market by Country, 2025 - 2032, USD Million
  • TABLE 17 Europe Academic Research Market by Country, 2021 - 2024, USD Million
  • TABLE 18 Europe Academic Research Market by Country, 2025 - 2032, USD Million
  • TABLE 19 Europe Computational Pathology Market by End-use, 2021 - 2024, USD Million
  • TABLE 20 Europe Computational Pathology Market by End-use, 2025 - 2032, USD Million
  • TABLE 21 Europe Hospitals and Diagnostic Labs Market by Country, 2021 - 2024, USD Million
  • TABLE 22 Europe Hospitals and Diagnostic Labs Market by Country, 2025 - 2032, USD Million
  • TABLE 23 Europe Biotechnology & Pharmaceutical Companies Market by Country, 2021 - 2024, USD Million
  • TABLE 24 Europe Biotechnology & Pharmaceutical Companies Market by Country, 2025 - 2032, USD Million
  • TABLE 25 Europe Academic and Research Institutes Market by Country, 2021 - 2024, USD Million
  • TABLE 26 Europe Academic and Research Institutes Market by Country, 2025 - 2032, USD Million
  • TABLE 27 Europe Other End-use Market by Country, 2021 - 2024, USD Million
  • TABLE 28 Europe Other End-use Market by Country, 2025 - 2032, USD Million
  • TABLE 29 Europe Computational Pathology Market by Technology, 2021 - 2024, USD Million
  • TABLE 30 Europe Computational Pathology Market by Technology, 2025 - 2032, USD Million
  • TABLE 31 Europe Machine Learning (ML) Market by Country, 2021 - 2024, USD Million
  • TABLE 32 Europe Machine Learning (ML) Market by Country, 2025 - 2032, USD Million
  • TABLE 33 Europe Computational Pathology Market by Machine Learning (ML) Type, 2021 - 2024, USD Million
  • TABLE 34 Europe Computational Pathology Market by Machine Learning (ML) Type, 2025 - 2032, USD Million
  • TABLE 35 Europe Deep Learning Market by Country, 2021 - 2024, USD Million
  • TABLE 36 Europe Deep Learning Market by Country, 2025 - 2032, USD Million
  • TABLE 37 Europe Other Machine Learning (ML) Market by Country, 2021 - 2024, USD Million
  • TABLE 38 Europe Other Machine Learning (ML) Market by Country, 2025 - 2032, USD Million
  • TABLE 39 Europe Computer Vision Market by Country, 2021 - 2024, USD Million
  • TABLE 40 Europe Computer Vision Market by Country, 2025 - 2032, USD Million
  • TABLE 41 Europe Natural Language Processing (NLP) Models Market by Country, 2021 - 2024, USD Million
  • TABLE 42 Europe Natural Language Processing (NLP) Models Market by Country, 2025 - 2032, USD Million
  • TABLE 43 Europe Other Technology Market by Country, 2021 - 2024, USD Million
  • TABLE 44 Europe Other Technology Market by Country, 2025 - 2032, USD Million
  • TABLE 45 Europe Computational Pathology Market by Country, 2021 - 2024, USD Million
  • TABLE 46 Europe Computational Pathology Market by Country, 2025 - 2032, USD Million
  • TABLE 47 Germany Computational Pathology Market, 2021 - 2024, USD Million
  • TABLE 48 Germany Computational Pathology Market, 2025 - 2032, USD Million
  • TABLE 49 Germany Computational Pathology Market by Component, 2021 - 2024, USD Million
  • TABLE 50 Germany Computational Pathology Market by Component, 2025 - 2032, USD Million
  • TABLE 51 Germany Computational Pathology Market by Application, 2021 - 2024, USD Million
  • TABLE 52 Germany Computational Pathology Market by Application, 2025 - 2032, USD Million
  • TABLE 53 Germany Computational Pathology Market by End-use, 2021 - 2024, USD Million
  • TABLE 54 Germany Computational Pathology Market by End-use, 2025 - 2032, USD Million
  • TABLE 55 Germany Computational Pathology Market by Technology, 2021 - 2024, USD Million
  • TABLE 56 Germany Computational Pathology Market by Technology, 2025 - 2032, USD Million
  • TABLE 57 Germany Computational Pathology Market by Machine Learning (ML) Type, 2021 - 2024, USD Million
  • TABLE 58 Germany Computational Pathology Market by Machine Learning (ML) Type, 2025 - 2032, USD Million
  • TABLE 59 UK Computational Pathology Market, 2021 - 2024, USD Million
  • TABLE 60 UK Computational Pathology Market, 2025 - 2032, USD Million
  • TABLE 61 UK Computational Pathology Market by Component, 2021 - 2024, USD Million
  • TABLE 62 UK Computational Pathology Market by Component, 2025 - 2032, USD Million
  • TABLE 63 UK Computational Pathology Market by Application, 2021 - 2024, USD Million
  • TABLE 64 UK Computational Pathology Market by Application, 2025 - 2032, USD Million
  • TABLE 65 UK Computational Pathology Market by End-use, 2021 - 2024, USD Million
  • TABLE 66 UK Computational Pathology Market by End-use, 2025 - 2032, USD Million
  • TABLE 67 UK Computational Pathology Market by Technology, 2021 - 2024, USD Million
  • TABLE 68 UK Computational Pathology Market by Technology, 2025 - 2032, USD Million
  • TABLE 69 UK Computational Pathology Market by Machine Learning (ML) Type, 2021 - 2024, USD Million
  • TABLE 70 UK Computational Pathology Market by Machine Learning (ML) Type, 2025 - 2032, USD Million
  • TABLE 71 France Computational Pathology Market, 2021 - 2024, USD Million
  • TABLE 72 France Computational Pathology Market, 2025 - 2032, USD Million
  • TABLE 73 France Computational Pathology Market by Component, 2021 - 2024, USD Million
  • TABLE 74 France Computational Pathology Market by Component, 2025 - 2032, USD Million
  • TABLE 75 France Computational Pathology Market by Application, 2021 - 2024, USD Million
  • TABLE 76 France Computational Pathology Market by Application, 2025 - 2032, USD Million
  • TABLE 77 France Computational Pathology Market by End-use, 2021 - 2024, USD Million
  • TABLE 78 France Computational Pathology Market by End-use, 2025 - 2032, USD Million
  • TABLE 79 France Computational Pathology Market by Technology, 2021 - 2024, USD Million
  • TABLE 80 France Computational Pathology Market by Technology, 2025 - 2032, USD Million
  • TABLE 81 France Computational Pathology Market by Machine Learning (ML) Type, 2021 - 2024, USD Million
  • TABLE 82 France Computational Pathology Market by Machine Learning (ML) Type, 2025 - 2032, USD Million
  • TABLE 83 Russia Computational Pathology Market, 2021 - 2024, USD Million
  • TABLE 84 Russia Computational Pathology Market, 2025 - 2032, USD Million
  • TABLE 85 Russia Computational Pathology Market by Component, 2021 - 2024, USD Million
  • TABLE 86 Russia Computational Pathology Market by Component, 2025 - 2032, USD Million
  • TABLE 87 Russia Computational Pathology Market by Application, 2021 - 2024, USD Million
  • TABLE 88 Russia Computational Pathology Market by Application, 2025 - 2032, USD Million
  • TABLE 89 Russia Computational Pathology Market by End-use, 2021 - 2024, USD Million
  • TABLE 90 Russia Computational Pathology Market by End-use, 2025 - 2032, USD Million
  • TABLE 91 Russia Computational Pathology Market by Technology, 2021 - 2024, USD Million
  • TABLE 92 Russia Computational Pathology Market by Technology, 2025 - 2032, USD Million
  • TABLE 93 Russia Computational Pathology Market by Machine Learning (ML) Type, 2021 - 2024, USD Million
  • TABLE 94 Russia Computational Pathology Market by Machine Learning (ML) Type, 2025 - 2032, USD Million
  • TABLE 95 Spain Computational Pathology Market, 2021 - 2024, USD Million
  • TABLE 96 Spain Computational Pathology Market, 2025 - 2032, USD Million
  • TABLE 97 Spain Computational Pathology Market by Component, 2021 - 2024, USD Million
  • TABLE 98 Spain Computational Pathology Market by Component, 2025 - 2032, USD Million
  • TABLE 99 Spain Computational Pathology Market by Application, 2021 - 2024, USD Million
  • TABLE 100 Spain Computational Pathology Market by Application, 2025 - 2032, USD Million
  • TABLE 101 Spain Computational Pathology Market by End-use, 2021 - 2024, USD Million
  • TABLE 102 Spain Computational Pathology Market by End-use, 2025 - 2032, USD Million
  • TABLE 103 Spain Computational Pathology Market by Technology, 2021 - 2024, USD Million
  • TABLE 104 Spain Computational Pathology Market by Technology, 2025 - 2032, USD Million
  • TABLE 105 Spain Computational Pathology Market by Machine Learning (ML) Type, 2021 - 2024, USD Million
  • TABLE 106 Spain Computational Pathology Market by Machine Learning (ML) Type, 2025 - 2032, USD Million
  • TABLE 107 Italy Computational Pathology Market, 2021 - 2024, USD Million
  • TABLE 108 Italy Computational Pathology Market, 2025 - 2032, USD Million
  • TABLE 109 Italy Computational Pathology Market by Component, 2021 - 2024, USD Million
  • TABLE 110 Italy Computational Pathology Market by Component, 2025 - 2032, USD Million
  • TABLE 111 Italy Computational Pathology Market by Application, 2021 - 2024, USD Million
  • TABLE 112 Italy Computational Pathology Market by Application, 2025 - 2032, USD Million
  • TABLE 113 Italy Computational Pathology Market by End-use, 2021 - 2024, USD Million
  • TABLE 114 Italy Computational Pathology Market by End-use, 2025 - 2032, USD Million
  • TABLE 115 Italy Computational Pathology Market by Technology, 2021 - 2024, USD Million
  • TABLE 116 Italy Computational Pathology Market by Technology, 2025 - 2032, USD Million
  • TABLE 117 Italy Computational Pathology Market by Machine Learning (ML) Type, 2021 - 2024, USD Million
  • TABLE 118 Italy Computational Pathology Market by Machine Learning (ML) Type, 2025 - 2032, USD Million
  • TABLE 119 Rest of Europe Computational Pathology Market, 2021 - 2024, USD Million
  • TABLE 120 Rest of Europe Computational Pathology Market, 2025 - 2032, USD Million
  • TABLE 121 Rest of Europe Computational Pathology Market by Component, 2021 - 2024, USD Million
  • TABLE 122 Rest of Europe Computational Pathology Market by Component, 2025 - 2032, USD Million
  • TABLE 123 Rest of Europe Computational Pathology Market by Application, 2021 - 2024, USD Million
  • TABLE 124 Rest of Europe Computational Pathology Market by Application, 2025 - 2032, USD Million
  • TABLE 125 Rest of Europe Computational Pathology Market by End-use, 2021 - 2024, USD Million
  • TABLE 126 Rest of Europe Computational Pathology Market by End-use, 2025 - 2032, USD Million
  • TABLE 127 Rest of Europe Computational Pathology Market by Technology, 2021 - 2024, USD Million
  • TABLE 128 Rest of Europe Computational Pathology Market by Technology, 2025 - 2032, USD Million
  • TABLE 129 Rest of Europe Computational Pathology Market by Machine Learning (ML) Type, 2021 - 2024, USD Million
  • TABLE 130 Rest of Europe Computational Pathology Market by Machine Learning (ML) Type, 2025 - 2032, USD Million
  • TABLE 131 Key Information - Koninklijke Philips N.V.
  • TABLE 132 Key Information - F. Hoffmann-La Roche Ltd.
  • TABLE 133 Key Information - PathAI, Inc.
  • TABLE 134 key information - Hamamatsu Photonics K.K.
  • TABLE 135 Key Information - Olympus Corporation
  • TABLE 136 Key Information - Visiopharm A/S
  • TABLE 137 Key Information - Mikroscan Technologies, Inc.
  • TABLE 138 Key Information - MindPeak GmbH
  • TABLE 139 Key Information - Indica Labs, Inc.
  • TABLE 140 Key Information - Nucleai, Inc.

LIST OF FIGURES

  • FIG 1 Methodology for the research
  • FIG 2 Europe Computational Pathology Market, 2021 - 2032, USD Million
  • FIG 3 Key Factors Impacting Computational Pathology Market
  • FIG 4 KBV Cardinal Matrix
  • FIG 5 Market Share Analysis, 2024
  • FIG 6 Key Leading Strategies: Percentage Distribution (2021-2025)
  • FIG 7 Key Strategic Move: (Partnerships, Collaborations & Agreements : 2022, Mar - 2025, Feb) Leading Players
  • FIG 8 Porter's Five Forces Analysis - Computational Pathology Market
  • FIG 9 Europe Computational Pathology Market share by Component, 2024
  • FIG 10 Europe Computational Pathology Market share by Component, 2032
  • FIG 11 Europe Computational Pathology Market by Component, 2021 - 2032, USD Million
  • FIG 12 Europe Computational Pathology Market share by Application, 2024
  • FIG 13 Europe Computational Pathology Market share by Application, 2032
  • FIG 14 Europe Computational Pathology Market by Application, 2021 - 2032, USD Million
  • FIG 15 Europe Computational Pathology Market share by End-use, 2024
  • FIG 16 Europe Computational Pathology Market share by End-use, 2032
  • FIG 17 Europe Computational Pathology Market by End-use, 2021 - 2032, USD Million
  • FIG 18 Europe Computational Pathology Market share by Technology, 2024
  • FIG 19 Europe Computational Pathology Market share by Technology, 2032
  • FIG 20 Europe Computational Pathology Market by Technology, 2021 - 2032, USD Million
  • FIG 21 Europe Computational Pathology Market share by Country, 2024
  • FIG 22 Europe Computational Pathology Market share by Country, 2032
  • FIG 23 Europe Computational Pathology Market by Country, 2021 - 2032, USD Million
  • FIG 24 SWOT Analysis: Koninklijke Philips N.V.
  • FIG 25 Recent strategies and developments: F. Hoffmann-La Roche Ltd.
  • FIG 26 SWOT Analysis: F. Hoffmann-La Roche Ltd.
  • FIG 27 Recent strategies and developments: PathAI, Inc.
  • FIG 28 Swot Analysis: PathAI, Inc.
  • FIG 29 Swot analysis: Hamamatsu Photonics K.K.
  • FIG 30 SWOT Analysis: Olympus Corporation
  • FIG 31 Recent strategies and developments: Visiopharm A/S
  • FIG 32 Swot Analysis: Visiopharm A/S
  • FIG 33 Swot Analysis: Indica Labs, Inc.
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!